These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Inhibition of river clam extract LX01 on human lung epithelial carcinoma cell line A549].
    Author: Wang SG, Li L.
    Journal: Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):917-20. PubMed ID: 15321761.
    Abstract:
    OBJECTIVE: To explore the inhibition effect of river clam extract LX01 on human lung epithelial carcinoma (A549) in mice. METHODS: The inhibition ratio of LX01 on A549 was detected by MTT method. A549 was inoculated into BALB/c mice, and 2 days later, LX01 (50, 100, 200 mg/kg.d) or cytoxan (0.02 mg/kg.d) were administrated for 15 days. Tumor weight, survival time and leukocyte count were measured. RESULTS: Tumor growth was markedly inhibited by LX01 in a dose- dependent manner. LX01 could significantly extend the survival time compared with the control group (P<0.01), but LX01 did not reduce leukocyte count of mice transplanted with A549. CONCLUSION: LX01 could efficiently inhibit the growth of A549 transplanted into mice and maintain the normal immunological function.
    [Abstract] [Full Text] [Related] [New Search]